We have previously demonstrated a relationship between circulating IGF-I and liver histological stages in a large cohort of obese children with NAFLD, suggesting that IGFs may be markers of liver damage progression in obese children [34]. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.